Kelly Maloney, MD

Recognitions

• Phi Beta Kappa, University of California, Davis (1986)
  
• Alpha Omega Alpha, University of Colorado Health Sciences Center (1989)
  
• Appleton and Lange Pediatric Award, University of Colorado Health Sciences Center (1990)
  
• Golden Apple Teaching Award, University of Colorado Health Sciences Center (1992)
  

Research Interests

Publications

• Seewald L, Taub JW, Maloney KW, McCabe ER. Acute leukemias in children with Down syndrome. Mol Genet Metab. 2012 Sep;107(1-2):25-30. PubMed PMID: 22867885
• Maloney KW, Giller R, Hunger SP. Recent advances in the understanding and treatment of pediatric leukemias. Adv Pediatr. 2012;59(1):329-58. PubMed PMID: 22789585
• Smita Bhatia, Wendy Landier, Lindsey Hageman, Heeyoung Kim, Cara Hanby, Kornegay Nancy, Bruce C. Bostrom, Jacqueline Casillas, David S Dickens, Kelly W. Maloney, Leo Mascarenhas, Jane Meza, Arthur Kim Ritchey, Amanda M Termuhlen, William L. Carroll, F. Lennie Wong, and Mary V. Relling. Nonadherence to Oral 6-Mercaptopurine (6MP) in a Multi-Ethnic Cohort of Children with Acute Lymphoblastic Leukemia (ALL) and Its Impact On Relapse – a Children's Oncology Group (COG) Study (AALL03N1). Blood Nov 2012: 814. Oral session
• Lau S, Balsamo L, Devidas M, Lu X, Winick N, Hunger S, Carroll W, Maloney K, Kadan-Lottick N. Family life events in the first year after diagnosis of standard risk (SR) acute lymphoblastic leukemia (ALL): A report from Children’s Oncology Group (COG) AALL0331. Pediatric Blood and Cancer: 58: 1041, 2012 (Poster presentation at ASPHO 2012).
• Myers RM, Balsamo L, Carroll W, Hunger S, Winick N, Devidas M, Lu X, Maloney K, Kadan-Lottick NS. Emotional and behavioral functioning in the first year after diagnosis of standard risk (SR) acute lymphoblastic leukemia (ALL): A report from Children’s Oncology Group (COG) AALL0331. Pediatric Blood and Cancer: 58: 1040, 2012 (Platform session presentation at ASPHO 2012).
• Loh ML, Raetz EA, Maloney K, Larsen E, Borowitz MJ, Carroll AJ, Devidas M, Heerema NA, Linda S, Wood B, Gastier-Foster J, Willman CL, Winick N, Hunger SP, Carroll WL. Outcome of acute lymphoblastic leukemia (ALL) patients with MLL gene rearrangements (MLLr) treated on contemporary Children’s Oncology Group (COG) protocols. Pediatr Blood Cancer 59: 1005, 2012 (oral presentation at SIOP, London, October 2012).
• Harvey RC, Wood BL, Chen IM, Doral MY, Yu K, Devidas M, Gastier-Foster JM, Larsen EC, Maloney KW, Raetz E, Winick N, Carroll WL, Hunger SP, Willman CL, Loh ML. Identification of CRLF2 genomic lesions in patients with pediatric B-precursor acute lymphoblastic leukemia (BCP ALL) by flow cytometry or quantitative RT-PCR: A Children’s Oncology Group (COG) study. Blood (ASH Annual Meeting Abstracts), Nov 2012; 120: 2529a (Poster presentation).
• Levy AS, Pyke-Grimm KA, Lee DA, Palla SL, Naranjo A, Sholler GS, Gratias E, Maloney K, Parshankar F, Lee-Scott M, Beierle EA, Gow K, Kim GE, Hunger S, Smith FO, Horton TM. Mentoring in Pediatric Oncology: A Report from the Children’s Oncology Group Young Investigator Committee. Journal of Pediatric Hematology/Oncology, In Press.
• Myers RM, Balsamo L, Lu X, Devidas M, Hunger SP, Carroll WL, Winick NJ, Maloney KW, Kadan-Lottick NS. A prospective study of anxiety, depression, and behavioral changes in the first year after a diagnosis of childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group. Cancer. 2014 Jan 28. [Epub ahead of print] PubMed PMID: 24473774
• Heerema NA, Carroll AJ, Devidas M, Loh ML, Borowitz MJ, Gastier-Foster JM, Larsen EC, Mattano LA Jr, Maloney KW, Willman CL, Wood BL, Winick NJ, Carroll WL, Hunger SP, Raetz EA. Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group. J Clin Oncol. 2013 Sep 20;31(27):3397-402. PubMed PMID: 23940221
• Levy AS, Pyke-Grimm KA, Lee DA, Palla SL, Naranjo A, Saulnier Sholler G, Gratias E, Maloney K, Parshankar F, Lee-Scott M, Beierle EA, Gow K, Kim GE, Hunger S, Smith FO, Horton TM. Mentoring in pediatric oncology: a report from the Children's Oncology Group Young Investigator Committee. J Pediatr Hematol Oncol. 2013 Aug;35(6):456-61. PubMed PMID: 23892351
• Hoffman LM, Gore L, Maloney KW. Pulmonary Presentation of Relapsed Acute Myeloid Leukemia. J Pediatr Hematol Oncol. 2013 Apr 24. [Epub ahead of print] PubMed PMID: 23619108
• Hoffman L, Gore L, Maloney KW. Pulmonary Presentation of Relapsed Acute Myeloid Leukemia. J of Pediatr Hematol Oncol
• Kelly W. Maloney, Meenakshi Devidas, Leonard A. Mattano Jr., Alison M. Friedmann, Patrick Buckley, Michael J. Borowitz, Andrew J. Carroll, Julie M. Gastier-Foster, Nyla A. Heerema, Nina Kadan -lottick, Mignon L. Loh, Yousif Matloub, David T. Marshall, Linda C. Stork, Elizabeth A. Raetz, Brent L. Wood, Naomi J. Winick, Stephen P. Hunger, and William L. Carroll. Excellent Event Free (EFS) and Overall Survival (OS) For Children With Standard Risk Acute Lymphoblastic Leukemia (SR ALL) Despite The Absence Of a Significant Impact On Outcome With The Addition Of An Intensified Consolidation: Results Of Children’s Oncology Group (COG) AALL0331 Blood 2013 122:837
• Lynda M. Vrooman, Ivan I. Kirov, Zoann E. Dreyer, Michael Kelly, Nobuko Hijiya, Patrick Brown, Richard A. Drachtman, Yoav H Messinger, A. Kim Ritchey, Gregory A. Hale, Kelly Maloney, Paul V. Plourde, and Lewis B. Silverman. Preliminary Results Of a Pharmacokinetic Study Of Intravenous Asparaginase Erwinia Chrysanthemi Following Allergy To E Coli-Derived Asparaginase In Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia Or Lymphoblastic Lymphoma. Blood 2013 122:3904
• Smita Bhatia, Wendy Landier, Lindsey Hageman, Can-Lan Sun, Heeyoung Kim, Nancy Kornegay, William E. Evans, Bruce C. Bostrom, Jacqueline Casillas, Anne Angiolillo, Glen Lew, Kelly Maloney, Leo Mascarenhas, Jane Meza, A. Kim Ritchey, Amanda Termuhlen, William L. Carroll, F. Lennie Wong, and Mary V. Relling. High Intra-Individual Variability In Systemic Exposure To 6 Mercaptopurine (6MP) In Children With Acute Lymphoblastic Leukemia (ALL) Contributes To ALL Relapse: Results From a Children’s Oncology Group (COG) Study (AALL03N1). Blood 2013 122:59
• Johann Hitzler, Meenakshi Devidas, James Whitlock, Bruce Camitta, Paul Gaynon, Karen Rabin, Kelly Maloney, Naomi Winick, William Carroll,Stephen Hunger. Survival of Children with Down Syndrome (DS) after a Relapse of Acute Lymphoblastic Leukemia: A Children’s Oncology Group (COG) study. Pediatric Blood Cancer, Volume 60, Issue S2, June 2013, S1.
• Regina Myers, Xiaomin Lu, Lyn Balsamo, William Carroll, Stephen Hunger,Naomi Winick, Meenakshi Devidas, Kelly Maloney, Nina Kadan-Lottick. Prospective, Longitudinal Assessment of Quality of Life in Children on active treatment for Standard Risk (SR) Acute Lymphoblastic Leukemia (all): a Report from Children’sOncology Group (COG) AALL0331. Pediatric Blood Cancer, Volume 60, Issue S2, June 2013,S40.
• Taizo Nakano, Courtney Daniels, Flori Legette, Jammie Reichel, Nancy Tena, Susan Dolan, Kelly Maloney, Joanne Hilden. Instituting a Pediatric Hematology/Oncology/Bmt Central Venous Catheter Care Bundle to Prevent Inpatient and Outpatient CLABSI. Pediatric Blood Cancer, Volume 60, Issue S2, June 2013, S84.
• Leonard A. Mattano, Meenakshi Devidas, Alison M. Friedmann, Elizabeth A. Raetz, Stephen Hunger, Naomi Joan Winick, William L. Carroll, Kelly W. Maloney, and Children's Oncology Group. Effect of dexamethasone (DEX) dose modification on osteonecrosis (ON) risk associated with intensified therapies for standard risk acute lymphoblastic leukemia (SR-ALL): A report from the Children's Oncology Group (COG) study AALL0331. ASCO MEETING ABSTRACTS Jun 17, 2013:10002
• Michael J. Borowitz, Brent L. Wood, Meenakshi Devidas, Mignon L. Loh, Elizabeth A. Raetz, Eric Larsen, Kelly W. Maloney, Andrew J Carroll, Alison M. Friedmann, Julie M Gastier-Foster, Nyla A. Heerema, Leonard A. Mattano, James B. Nachman, Naomi Joan Winick, William L. Carroll, and Stephen Hunger. Assessment of end induction minimal residual disease (MRD) in childhood B precursor acute lymphoblastic leukemia (ALL) to eliminate the need for day 14 marrow examination: A Children's Oncology Group study. ASCO MEETING ABSTRACTS Jun 17, 2013:10001
• Smita Bhatia, MD, MPH, Wendy Landier, PhD, RN, Lindsey Hageman, MPH, Heeyoung Kim, MPH, Yanjun Chen, MS, Can-Lan Sun, PhD, Nancy Kornegay, MS, William E Evans, PharmD,Anne L Angiolillo, MD, Bruce Bostrom, Jacqueline Casillas, MD, MSHS, Glen Lew, MD, Kelly W Maloney, MD, Leo Mascarenhas, MD, MS, Jane Meza, PhD, A. Kim Ritchey, MD, Amanda M Termuhlen, MD, William L Carroll, MD, F Lennie Wong, PhD, Mary V Relling, PharmD. Contribution of Thiopurine Systemic Exposure to Relapse Risk in Children with Acute Lymphoblastic Leukemia: A Children’s Oncology Group Study.
• Lau S, Lu X, Balsamo L, Devidas M, Winick N, Hunger SP, Carroll W, Stork L, Maloney K, Kadan-Lottick N. Family life events in the first year of acute lymphoblastic leukemia therapy: a children's oncology group report. Pediatr Blood Cancer. 2014 Dec;61(12):2277-84. PubMed PMID: 25175168
• Bhatia S, Landier W, Hageman L, Kim H, Chen Y, Crews KR, Evans WE, Bostrom B, Casillas J, Dickens DS, Maloney KW, Neglia JP, Ravindranath Y, Ritchey AK, Wong FL, Relling MV. 6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 2014 Oct 9;124(15):2345-53. PubMed PMID: 24829202
• Myers RM, Balsamo L, Lu X, Devidas M, Hunger SP, Carroll WL, Winick NJ, Maloney KW, Kadan-Lottick NS. A prospective study of anxiety, depression, and behavioral changes in the first year after a diagnosis of childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Cancer. 2014 May 1;120(9):1417-25. PubMed PMID: 24473774
• Hoffman LM, Gore L, Maloney KW. Pulmonary presentation of relapsed acute myeloid leukemia. J Pediatr Hematol Oncol. 2014 Apr;36(3):228-30. PubMed PMID: 23619108
• EVENT FREE (EFS) AND OVERALL SURVIVAL (OS) FOR CHILDREN WITH DOWN SYNDROME (DS) AND B-LYMPHOBLASTIC LEUKEMIA (BALL) IN CHILDREN’S ONCOLOGY GROUP (COG) CLINICAL TRIALS AALL0232 AND AALL0331 Kelly Maloney, Eric Larsen, Meenakshi Devidas, Len Mattano, Alison Friedmann, Jule M. Gastier-Foster, Drew Carroll, Nyla Heerema, Michael Borowitz, Brent Wood, James Whitlock, Mignon Loh, Elizabeth
• CORTICOSTEROID PRETREATMENT IS NOT AN INDEPENDENT RISK FACTOR IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED BLYMPHOBLASTIC LEUKEMIA (B-ALL): RESULTS FROM CHILDREN’S ONCOLOGY GROUP (COG) STUDY AALL03B1 Elizabeth Raetz, Brent Wood, Michael Borowitz, Naomi Winick, Stephen Hunger, William Carroll, Mignon Loh, Meenakshi Devidas, Kelly Maloney, Len Mattano, Eric Larsen, Andrew Carroll, Nyla Heerema, Julie Gastier-Foster
• Factors associated with nonadherence to oral 6-mercaptopurine (6MP) in children with acute lymphoblastic leukemia (ALL): A report from Children’s Oncology Group (COG) study AALL03N1. Wendy Landier, Yanjun Chen, Lindsey Hageman, Heeyoung Kim, Bruce C. Bostrom, Jacqueline N. Casillas, David S. Dickens, William E. Evans, Kelly W. Maloney, Leo Mascarenhas, Arthur Kim Ritchey, Amanda M. Termuhlen, William L. Carroll, Mary V. Relling, Florence Lennie Wong and Smita Bhatia
• The impact of initial cerebrospinal fluid (CSF) findings on outcome among patients with NCI standard (SR) and high-risk (HR) B-lymphoblastic leukemia (ALL): A report from the Children's Oncology Group (COG) Studies AALL0331 and AALL0232. Naomi Joan Winick, Meenakshi Devidas, Kelly W. Maloney, Eric Larsen, Leonard A. Mattano, Michael J. Borowitz, Andrew J Carroll, Julie M Gastier-Foster, Nyla A. Heerema, Cheryl L. Willman, Brent L. Wood, Mignon L. Loh, Elizabeth A. Raetz, Stephen Hunger, and William L. Carroll ASCO MEETING ABSTRACTS Jun 11, 2014:10016
• Outstanding Outcome for Children with Standard Risk-Low (SR-Low) Acute Lymphoblastic Leukemia (ALL) and No Benefit to Intensified Peg-Asparaginase (PEG-ASNase) Therapy: Results of Children’s Oncology Group (COG) Study AALL0331 Leonard A. Mattano, MD1, Meenakshi Devidas, PhD2, Alison M. Friedmann, MD MSC*,3, Elizabeth A. Raetz, MD4, Mignon Loh, MD5, Patrick Buckley, MD PhD*,6, Michael J. Borowitz, MD PhD7, Andrew J. Carroll, PhD8, Julie Gastier-Foster, PhD9, Nyla A. Heerema, PhD10, Nina Kadan-Lottick, MD MSPH*,11, Yousif Matloub, MD12, David T Marshall, MD*,13, Linda C. Stork, MD14, Brent L. Wood, MD PhD15, Naomi J. Winick, MD16, Stephen Hunger, MD17, William L. Carroll, MD18, and Kelly Maloney, MD19
• Impact of 6 Mercaptopurine (6MP) Pill-Taking Habits on Adherence, Thioguanine Nucleotide (TGN) Levels and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): Results from a Children’s Oncology Group (COG) Study (AALL03N1) Lindsey Hageman*,1, Wendy Landier, PhD, R.N.*,2, Yanjun Chen, MS*,3, Heeyoung Kim, M.S.*,2, Nancy Kornegay, M.S.*,4, William E. Evans, PharmD5, Bruce C. Bostrom, MD6, Jacqueline Casillas, MD, M.S.H.S.*,7, David Dickens, MD*,8, Anne Angiolillo, MD*,9, Glen Lew, MD10, Kelly Maloney, MD11, Leo Mascarenhas12, Arthur K. Ritchey, MD13, Amanda Termuhlen, MD*,14, William L. Carroll, MD15, Mary V. Relling, PharmD16, F. Lennie Wong*,1, and Smita Bhatia, PhD1
• Karol SE, Mattano LA Jr, Yang W, Maloney KW, Smith C, Liu C, Ramsey LB, Fernandez CA, Chang TY, Neale G, Cheng C, Mardis E, Fulton R, Scheet P, San Lucas FA, Larsen EC, Loh ML, Raetz EA, Hunger SP, Devidas M, Relling MV. Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia. Blood. 2015 Nov 20. [Epub ahead of print] PubMed PMID: 26590194
• Vrooman LM, Kirov II, Dreyer ZE, Kelly M, Hijiya N, Brown P, Drachtman RA, Messinger YH, Ritchey AK, Hale GA, Maloney K, Lu Y, Plourde PV, Silverman LB. Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia. Pediatr Blood Cancer. 2015 Sep 16. [Epub ahead of print] PubMed PMID: 26376459
• Mitchell HR, Lu X, Myers RM, Sung L, Balsamo LM, Carroll WL, Raetz E, Loh ML, Mattano LA Jr, Winick NJ, Devidas M, Hunger SP, Maloney K, Kadan-Lottick NS. Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331. Int J Cancer. 2015 Aug 1. [Epub ahead of print] PubMed PMID: 26235006
• Bhatia S, Landier W, Hageman L, Chen Y, Kim H, Sun CL, Kornegay N, Evans WE, Angiolillo AL, Bostrom B, Casillas J, Lew G, Maloney KW, Mascarenhas L, Ritchey AK, Termuhlen AM, Carroll WL, Wong FL, Relling MV. Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study. JAMA Oncol. 2015 Jun;1(3):287-95. PubMed PMID: 26181173
• Maloney KW, Taub JW, Ravindranath Y, Roberts I, Vyas P. Down syndrome preleukemia and leukemia. Pediatr Clin North Am. 2015 Feb;62(1):121-37. PubMed PMID: 25435116
• Kelly W. Maloney, Anne L. Angiolillo, Reuven J. Schore, Meenakshi Devidas, Xiaomin Lu, Cindy Wang, Alison M. Friedmann, Leonard A. Mattano, Mignon L. Loh, Elizabeth A. Raetz, Linda C. Stork, Naomi J. Winick, Stephen Hunger,and William L. Carroll Association of intravenous (IV) and intramuscular (IM) pegaspargase (PEG) administration with rate of adverse events (AE) in standard risk (SR) Acute Lymphoblastic Leukemia (ALL) Children's Oncology Group (COG) trials. ASCO MEETING ABSTRACTS May 18, 2015:10035
• Elizabeth Raetz, Mignon L. Loh, Meenakshi Devidas, Kelly Maloney, Eric C. Larsen, Leonard A. Mattano Jr., Michael J. Borowitz, Brent L Wood, Andrew J. Carroll, Nyla A. Heerema, I-Ming Chen, Alison M. Friedmann, Kirk R. Schultz, Mary V. Relling, Richard C Harvey, Julie Gastier-Foster, Cheryl L. Willman, Naomi J. Winick, Stephen P. Hunger, and William L. Carroll. Genetic and Response-Based Risk Classification Identifies a Subgroup of NCI High Risk Childhood B-Lymphoblastic Leukemia (HR B-ALL) with Outstanding Outcomes: A Report from the Children's Oncology Group (COG). ASH annual meeting, 2015
• Gu Z, Churchman M, Roberts K, Li Y, Liu Y, Harvey RC, McCastlain K, Reshmi SC, Payne-Turner D, Iacobucci I, Shao Y, Chen IM, Valentine M, Pei D, Mungall KL, Mungall AJ, Ma Y, Moore R, Marra M, Stonerock E, Gastier-Foster JM, Devidas M, Dai Y, Wood B, Borowitz M, Larsen EE, Maloney K, Mattano LA Jr, Angiolillo A, Salzer WL, Burke MJ, Gianni F, Spinelli O, Radich JP, Minden MD, Moorman AV, Patel B, Fielding AK, Rowe JM, Luger SM, Bhatia R, Aldoss I, Forman SJ, Kohlschmidt J, Mrózek K, Marcucci G, Bloomfield CD, Stock W, Kornblau S, Kantarjian HM, Konopleva M, Paietta E, Willman CL, L Loh M, P Hunger S, Mullighan CG. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia. Nat Commun. 2016 Nov 8;7:13331. PubMed PMID: 27824051
• Seth E. Karol, Wenjian Yang, Leonard A. Mattano Jr, Kelly W. Maloney, Colton Smith, ChengCheng Liu, Laura B. Ramsey, Christian A. Fernandez, Tamara Y. Chang,Geoffrey Neale, Cheng Cheng, Elaine Mardis, Robert Fulton, Paul Scheet, Eric C. Larsen, Mignon L. Loh, Elizabeth A. Raetz, Stephen P. Hunger, Meenakshi Devidas, Mary V. Relling. Genetic Risk Factors for the Development of Osteonecrosis in Children Under Age 10 Treated for Acute Lymphoblastic Leukemia. ASH annual meeting, 2015
• Karen R. Rabin, Johann Hitzler, Vilmarie Rodriguez, Reuven J. Schore, Anne L. Angiolillo, Michael J. Burke, Wanda L. Salzer, Kelly W. Maloney, Xiaomin Lu, Meenakshi Devidas, Mignon L. Loh, Elizabeth A. Raetz, Stephen P. Hunger. Treatment-Related Mortality (TRM) in Children with Down Syndrome (DS) and B-Lymphoblastic Leukemia (B-ALL): An Interim Report from the Children’s Oncology Group Trials AALL0932 and AALL1131. ASH annual meeting, 2015
• Rogers AE, Eisenman KM, Dolan SA, Belderson KM, Zauche JR, Tong S, Gralla J, Hilden JM, Wang M, Maloney KW, Dominguez SR. Risk factors for bacteremia and central line-associated blood stream infections in children with acute myelogenous leukemia: A single-institution report. Pediatr Blood Cancer. 2016 Sep 12. [Epub ahead of print] PubMed PMID: 27616655
• Kolenova A, Maloney KW, Hunger SP. Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis. J Pediatr Hematol Oncol. 2016 Aug;38(6):e193-5. PubMed PMID: 27164534
• Liu C, Yang W, Devidas M, Cheng C, Pei D, Smith C, Carroll WL, Raetz EA, Bowman WP, Larsen EC, Maloney KW, Martin PL, Mattano LA Jr, Winick NJ, Mardis ER, Fulton RS, Bhojwani D, Howard SC, Jeha S, Pui CH, Hunger SP, Evans WE, Loh ML, Relling MV. Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia. J Clin Oncol. 2016 Jun 20;34(18):2133-40. PubMed PMID: 27114598
• Kunin-Batson AS, Lu X, Balsamo L, Graber K, Devidas M, Hunger SP, Carroll WL, Winick NJ, Mattano LA Jr, Maloney KW, Kadan-Lottick NS. Prevalence and predictors of anxiety and depression after completion of chemotherapy for childhood acute lymphoblastic leukemia: A prospective longitudinal study. Cancer. 2016 May 15;122(10):1608-17. PubMed PMID: 27028090
• Dupuis LL, Lu X, Mitchell HR, Sung L, Devidas M, Mattano LA Jr, Carroll WL, Winick N, Hunger SP, Maloney KW, Kadan-Lottick NS. Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group. Cancer. 2016 Apr 1;122(7):1116-25. PubMed PMID: 26773735
• Karol SE, Mattano LA Jr, Yang W, Maloney KW, Smith C, Liu C, Ramsey LB, Fernandez CA, Chang TY, Neale G, Cheng C, Mardis E, Fulton R, Scheet P, San Lucas FA, Larsen EC, Loh ML, Raetz EA, Hunger SP, Devidas M, Relling MV. Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia. Blood. 2016 Feb 4;127(5):558-64. PubMed PMID: 26590194
• Vrooman LM, Kirov II, Dreyer ZE, Kelly M, Hijiya N, Brown P, Drachtman RA, Messinger YH, Ritchey AK, Hale GA, Maloney K, Lu Y, Plourde PV, Silverman LB. Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia. Pediatr Blood Cancer. 2016 Feb;63(2):228-33. PubMed PMID: 26376459
• Mitchell HR, Lu X, Myers RM, Sung L, Balsamo LM, Carroll WL, Raetz E, Loh ML, Mattano LA Jr, Winick NJ, Devidas M, Hunger SP, Maloney K, Kadan-Lottick NS. Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331. Int J Cancer. 2016 Jan 15;138(2):332-9. PubMed PMID: 26235006
• Wood B, Wu D, Crossley B, Dai Y, Williamson D, Gawad C, Borowitz MJ, Devidas M, Maloney KW, Larsen E, Winick N, Raetz E, Carroll WL, Hunger SP, Loh M, Robins H, Kirsch I. Measurable residual disease detection by high throughput sequencing improves risk stratification for pediatric B-ALL. Blood. 2017 Dec 28. [Epub ahead of print] PubMed PMID: 29284596
• Esbenshade AJ, Pierson CR, Thompson AL, Reed D, Gupta A, Levy A, Kahalley LS, Harker-Murray P, Schore R, Muscal JA, Embry L, Maloney K, Horton T, Zweidler-Mckay P, Dhall G. Long-term evidence that a pediatric oncology mentorship program for young investigators is feasible and beneficial in the cooperative group setting: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2017 Nov 28. [Epub ahead of print] PubMed PMID: 29193588
• Maloney KW, Gore L. Agents in Development for Childhood Acute Lymphoblastic Leukemia. Paediatr Drugs. 2017 Nov 15. [Epub ahead of print] PubMed PMID: 29143289
• Burke MJ, Devidas M, Maloney K, Angiolillo A, Schore R, Dunsmore K, Larsen E, Mattano LA Jr, Salzer W, Winter SS, Carroll W, Winick NJ, Loh ML, Raetz E, Hunger SP, Bleyer A. Severe pegaspargase hypersensitivity reaction rates (grade =3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trials. Leuk Lymphoma. 2017 Nov 8;:1-10. [Epub ahead of print] PubMed PMID: 29115886
• Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, Hagiwara K, Pelletier S, Gingras S, Berns H, Payne-Turner D, Hill A, Iacobucci I, Shi L, Pounds S, Cheng C, Pei D, Qu C, Newman S, Devidas M, Dai Y, Reshmi SC, Gastier-Foster J, Raetz EA, Borowitz MJ, Wood BL, Carroll WL, Zweidler-McKay PA, Rabin KR, Mattano LA, Maloney KW, Rambaldi A, Spinelli O, Radich JP, Minden MD, Rowe JM, Luger S, Litzow MR, Tallman MS, Racevskis J, Zhang Y, Bhatia R, Kohlschmidt J, Mrózek K, Bloomfield CD, Stock W, Kornblau S, Kantarjian HM, Konopleva M, Evans WE, Jeha S, Pui CH, Yang J, Paietta E, Downing JR, Relling MV, Zhang J, Loh ML, Hunger SP, Mullighan CG. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet. 2019 Jan 14. [Epub ahead of print] PubMed PMID: 30643249
• Winick N, Devidas M, Chen S, Maloney K, Larsen E, Mattano L, Borowitz MJ, Carroll A, Gastier-Foster JM, Heerema NA, Willman C, Wood B, Loh ML, Raetz E, Hunger SP, Carroll WL. Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group. J Clin Oncol. 2017 Aug 1;35(22):2527-2534. PubMed PMID: 28535084
• Ross S, Eisenman K, Maloney KW. Successful Use of EPOCH-R in 2 Young Adult Patients With Burkitt Lymphoma and Acute Kidney Injury: A Case Report. J Pediatr Hematol Oncol. 2018 Aug 8. [Epub ahead of print] PubMed PMID: 30095692
• Roberts KG, Reshmi SC, Harvey RC, Chen IM, Patel K, Stonerock E, Jenkins H, Dai Y, Valentine M, Gu Z, Zhao Y, Zhang J, Payne-Turner D, Devidas M, Heerema NA, Carroll AJ, Raetz EA, Borowitz MJ, Wood BL, Mattano LA Jr, Maloney KW, Carroll WL, Loh ML, Willman CL, Gastier-Foster JM, Mullighan CG, Hunger SP. Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group. Blood. 2018 Aug 23;132(8):815-824. PubMed PMID: 29997224
• Gupta S, Devidas M, Loh ML, Raetz EA, Chen S, Wang C, Brown P, Carroll AJ, Heerema NA, Gastier-Foster JM, Dunsmore KP, Larsen EC, Maloney KW, Mattano LA Jr, Winter SS, Winick NJ, Carroll WL, Hunger SP, Borowitz MJ, Wood BL. Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (COG). Leukemia. 2018 Jun;32(6):1370-1379. PubMed PMID: 29472723
• Landier W, Hageman L, Chen Y, Kornegay N, Evans WE, Bostrom BC, Casillas J, Dickens DS, Angiolillo AL, Lew G, Maloney KW, Mascarenhas L, Ritchey AK, Termuhlen AM, Carroll WL, Relling MV, Wong FL, Bhatia S. Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1. J Clin Oncol. 2017 May 20;35(15):1730-1736. PubMed PMID: 28339328
• Maloney JP, Branchford BR, Brodsky GL, Cosmic MS, Calabrese DW, Aquilante CL, Maloney KW, Gonzalez JR, Zhang W, Moreau KL, Wiggins KL, Smith NL, Broeckel U, Di Paola J. The ENTPD1 promoter polymorphism -860 A > G (rs3814159) is associated with increased gene transcription, protein expression, CD39/NTPDase1 enzymatic activity, and thromboembolism risk. FASEB J. 2017 Jul;31(7):2771-2784. PubMed PMID: 28302652
• Wood B, Wu D, Crossley B, Dai Y, Williamson D, Gawad C, Borowitz MJ, Devidas M, Maloney KW, Larsen E, Winick N, Raetz E, Carroll WL, Hunger SP, Loh ML, Robins H, Kirsch I. Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL. Blood. 2018 Mar 22;131(12):1350-1359. PubMed PMID: 29284596
• Landier W, Chen Y, Hageman L, Kim H, Bostrom BC, Casillas JN, Dickens DS, Evans WE, Maloney KW, Mascarenhas L, Ritchey AK, Termuhlen AM, Carroll WL, Relling MV, Wong FL, Bhatia S. Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study. Blood. 2017 Apr 6;129(14):1919-1926. PubMed PMID: 28153823
• Esbenshade AJ, Pierson CR, Thompson AL, Reed D, Gupta A, Levy A, Kahalley LS, Harker-Murray P, Schore R, Muscal JA, Embry L, Maloney K, Horton T, Zweidler-Mckay P, Dhall G. Long-term evidence that a pediatric oncology mentorship program for young investigators is feasible and beneficial in the cooperative group setting: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2018 Mar;65(3). PubMed PMID: 29193588
• Maloney KW, Gore L. Agents in Development for Childhood Acute Lymphoblastic Leukemia. Paediatr Drugs. 2018 Apr;20(2):111-120. PubMed PMID: 29143289
• Burke MJ, Devidas M, Maloney K, Angiolillo A, Schore R, Dunsmore K, Larsen E, Mattano LA Jr, Salzer W, Winter SS, Carroll W, Winick NJ, Loh ML, Raetz E, Hunger SP, Bleyer A. Severe pegaspargase hypersensitivity reaction rates (grade =3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trials. Leuk Lymphoma. 2018 Jul;59(7):1624-1633. PubMed PMID: 29115886
• Rogers AE, Eisenman KM, Dolan SA, Belderson KM, Zauche JR, Tong S, Gralla J, Hilden JM, Wang M, Maloney KW, Dominguez SR. Risk factors for bacteremia and central line-associated blood stream infections in children with acute myelogenous leukemia: A single-institution report. Pediatr Blood Cancer. 2017 Mar;64(3). PubMed PMID: 27616655
• Carroll AJ, Shago M, Mikhail FM, Raimondi SC, Hirsch BA, Loh ML, Raetz EA, Borowitz MJ, Wood BL, Maloney KW, Mattano LA Jr, Larsen EC, Gastier-Foster J, Stonerock E, Ell D, Kahwash S, Devidas M, Harvey RC, Chen IL, Willman CL, Hunger SP, Winick NJ, Carroll WL, Rao KW, Heerema NA. Masked hypodiploidy: Hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: A report from the Children's Oncology Group. Cancer Genet. 2019 Oct;238:62-68. PubMed PMID: 31425927
• Keating AK, Gossai N, Phillips CL, Maloney K, Campbell K, Doan A, Bhojwani D, Burke MJ, Verneris MR. Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemia. Blood Adv. 2019 Jul 9;3(13):1926-1929. PubMed PMID: 31243002
• Raetz EA, Loh ML, Devidas M, Maloney K, Mattano LA Jr, Larsen E, Carroll A, Heerema NA, Gastier-Foster JM, Wood B, Borowitz MJ, Winick N, Hunger SP, Carroll WL. Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: a report from the Children's Oncology Group. Haematologica. 2019 Nov;104(11):e517-e520. PubMed PMID: 31004024
• McNeer JL, Devidas M, Dai Y, Carroll AJ, Heerema NA, Gastier-Foster JM, Kahwash SB, Borowitz MJ, Wood BL, Larsen E, Maloney KW, Mattano L, Winick NJ, Schultz KR, Hunger SP, Carroll WL, Loh ML, Raetz EA. Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group. J Clin Oncol. 2019 Apr 1;37(10):780-789. PubMed PMID: 30742559
• Ross S, Eisenman K, Maloney KW. Successful Use of EPOCH-R in 2 Young Adult Patients With Burkitt Lymphoma and Acute Kidney Injury: A Case Report. J Pediatr Hematol Oncol. 2019 Aug;41(6):498-500. PubMed PMID: 30095692
• Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, Hagiwara K, Pelletier S, Gingras S, Berns H, Payne-Turner D, Hill A, Iacobucci I, Shi L, Pounds S, Cheng C, Pei D, Qu C, Newman S, Devidas M, Dai Y, Reshmi SC, Gastier-Foster J, Raetz EA, Borowitz MJ, Wood BL, Carroll WL, Zweidler-McKay PA, Rabin KR, Mattano LA, Maloney KW, Rambaldi A, Spinelli O, Radich JP, Minden MD, Rowe JM, Luger S, Litzow MR, Tallman MS, Racevskis J, Zhang Y, Bhatia R, Kohlschmidt J, Mrózek K, Bloomfield CD, Stock W, Kornblau S, Kantarjian HM, Konopleva M, Evans WE, Jeha S, Pui CH, Yang J, Paietta E, Downing JR, Relling MV, Zhang J, Loh ML, Hunger SP, Mullighan CG. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet. 2019 Feb;51(2):296-307. PubMed PMID: 30643249
• Maloney KW, Devidas M, Wang C, Mattano LA, Friedmann AM, Buckley P, Borowitz MJ, Carroll AJ, Gastier-Foster JM, Heerema NA, Kadan-Lottick N, Loh ML, Matloub YH, Marshall DT, Stork LC, Raetz EA, Wood B, Hunger SP, Carroll WL, Winick NJ. Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331.J Clin Oncol. 2019 Dec 11:JCO1901086. doi: 10.1200/JCO.19.01086
• Davies K, Barth M, Armenian S, Audino AN, Barnette P, Cuglievan B, Ding H, Ford JB, Galardy PJ, Gardner R, Hanna R, Hayashi R, Kovach AE, Machnitz AJ, Maloney KW, Marks L, Page K, Reilly AF, Weinstein JL, Xavier AC, McMillian NR, Freedman-Cass DA. Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Aug;18(8):1105-1123. PubMed PMID: 32755986
• Winters AC, Maloney KW, Treece AL, Gore L, Franklin AK. Single-center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemia. Pediatr Blood Cancer. 2020 Oct;67(10):e28398. PubMed PMID: 32735397
• Gupta S, Wang C, Raetz EA, Schore R, Salzer WL, Larsen EC, Maloney KW, Mattano LA Jr, Carroll WL, Winick NJ, Hunger SP, Loh ML, Devidas M. Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group. J Clin Oncol. 2020 Jun 10;38(17):1897-1905. PubMed PMID: 32275469
• Maloney KW, Devidas M, Wang C, Mattano LA, Friedmann AM, Buckley P, Borowitz MJ, Carroll AJ, Gastier-Foster JM, Heerema NA, Kadan-Lottick N, Loh ML, Matloub YH, Marshall DT, Stork LC, Raetz EA, Wood B, Hunger SP, Carroll WL, Winick NJ. Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331. J Clin Oncol. 2020 Feb 20;38(6):602-612. PubMed PMID: 31825704
• Getz KD, Szymczak JE, Li Y, Madding R, Huang YV, Aftandilian C, Arnold SD, Bona KO, Caywood E, Collier AB, Gramatges MM, Henry M, Lotterman C, Maloney K, Mian A, Mody R, Morgan E, Raetz EA, Rubnitz J, Verma A, Winick N, Wilkes JJ, Yu JC, Fisher BT, Aplenc R. Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia. JAMA Netw Open. 2021 Oct 1;4(10):e2128385. PubMed PMID: 34709389
• Dolan SA, Mulcahy Levy J, Moss A, Pearce K, Butler M, Jung S, Dominguez SR, Mwangi E, Maloney K, Rao S. SARS-CoV-2 persistence in immunocompromised children. Pediatr Blood Cancer. 2021 Dec;68(12):e29277. PubMed PMID: 34453477
• Fleming JM, Ross S, Hoffman LM, Coughlin R, Crombleholme TM, Mong DA, Hilden J, Maloney K, Tan GM. Pediatric mediastinal mass algorithm: A quality improvement initiative to reduce time from presentation to biopsy. Paediatr Anaesth. 2021 Aug;31(8):885-893. PubMed PMID: 34002917
• Mattano LA Jr, Devidas M, Maloney KW, Wang C, Friedmann AM, Buckley P, Borowitz MJ, Carroll AJ, Gastier-Foster JM, Heerema NA, Kadan-Lottick NS, Matloub YH, Marshall DT, Stork LC, Loh ML, Raetz EA, Wood BL, Hunger SP, Carroll WL, Winick NJ. Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331. J Clin Oncol. 2021 May 10;39(14):1540-1552. PubMed PMID: 33739852
• Pikman Y, Tasian SK, Sulis ML, Stevenson K, Blonquist TM, Apsel Winger B, Cooper TM, Pauly M, Maloney KW, Burke MJ, Brown PA, Gossai N, McNeer JL, Shukla NN, Cole PD, Kahn JM, Chen J, Barth MJ, Magee JA, Gennarini L, Adhav AA, Clinton CM, Ocasio-Martinez N, Gotti G, Li Y, Lin S, Imamovic A, Tognon CE, Patel T, Faust HL, Contreras CF, Cremer A, Cortopassi WA, Garrido Ruiz D, Jacobson MP, Dharia NV, Su A, Robichaud AL, Saur Conway A, Tarlock K, Stieglitz E, Place AE, Puissant A, Hunger SP, Kim AS, Lindeman NI, Gore L, Janeway KA, Silverman LB, Tyner JW, Harris MH, Loh ML, Stegmaier K. Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium. Cancer Discov. 2021 Jun;11(6):1424-1439. PubMed PMID: 33563661
• Angiolillo AL, Schore RJ, Kairalla JA, Devidas M, Rabin KR, Zweidler-McKay P, Borowitz MJ, Wood B, Carroll AJ, Heerema NA, Relling MV, Hitzler J, Lane AR, Maloney KW, Wang C, Bassal M, Carroll WL, Winick NJ, Raetz EA, Loh ML, Hunger SP. Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932. J Clin Oncol. 2021 May 1;39(13):1437-1447. PubMed PMID: 33411585
• Barth M, Xavier AC, Armenian S, Audino AN, Blazin L, Bloom D, Chung J, Davies K, Ding H, Ford JB, Galardy PJ, Hanna R, Hayashi R, Lee-Miller C, Machnitz AJ, Maloney KW, Marks L, Martin PL, McCall D, Pacheco M, Reilly AF, Roshal M, Song S, Weinstein J, Zarnegar-Lumley S, McMillian N, Schonfeld R, Sundar H. Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 Nov;20(11):1267-1275. PubMed PMID: 36351334
• Brady SW, Roberts KG, Gu Z, Shi L, Pounds S, Pei D, Cheng C, Dai Y, Devidas M, Qu C, Hill AN, Payne-Turner D, Ma X, Iacobucci I, Baviskar P, Wei L, Arunachalam S, Hagiwara K, Liu Y, Flasch DA, Liu Y, Parker M, Chen X, Elsayed AH, Pathak O, Li Y, Fan Y, Michael JR, Rusch M, Wilkinson MR, Foy S, Hedges DJ, Newman S, Zhou X, Wang J, Reilly C, Sioson E, Rice SV, Pastor Loyola V, Wu G, Rampersaud E, Reshmi SC, Gastier-Foster J, Guidry Auvil JM, Gesuwan P, Smith MA, Winick N, Carroll AJ, Heerema NA, Harvey RC, Willman CL, Larsen E, Raetz EA, Borowitz MJ, Wood BL, Carroll WL, Zweidler-McKay PA, Rabin KR, Mattano LA, Maloney KW, Winter SS, Burke MJ, Salzer W, Dunsmore KP, Angiolillo AL, Crews KR, Downing JR, Jeha S, Pui CH, Evans WE, Yang JJ, Relling MV, Gerhard DS, Loh ML, Hunger SP, Zhang J, Mullighan CG. The genomic landscape of pediatric acute lymphoblastic leukemia. Nat Genet. 2022 Sep;54(9):1376-1389. PubMed PMID: 36050548
• Elgarten CW, Otto WR, Shenton L, Stein MT, Horowitz J, Aftandilian C, Arnold SD, Bona KO, Caywood E, Collier AB, Gramatges MM, Henry M, Lotterman C, Maloney K, Modi AJ, Mian A, Mody R, Morgan E, Raetz EA, Verma A, Winick N, Wilkes JJ, Yu JC, Aplenc R, Fisher BT, Getz KD. Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia. Infect Control Hosp Epidemiol. 2022 Apr 25;:1-8. [Epub ahead of print] PubMed PMID: 35465865
• Gupta S, Teachey DT, Chen Z, Rabin KR, Dunsmore KP, Larsen EC, Maloney KW, Mattano LA Jr, Winter SS, Carroll AJ, Heerema NA, Borowitz MJ, Wood BL, Carroll WL, Raetz EA, Winick NJ, Loh ML, Hunger SP, Devidas M. Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report. Cancer. 2022 May 1;128(9):1863-1870. PubMed PMID: 35201611
• Murphy L, Maloney K, Gore L, Blanchette E. Hypertension in Pediatric Acute Lymphoblastic Leukemia Patients: Prevalence, Impact, and Management Strategies. Integr Blood Press Control. 2022;15:1-10. PubMed PMID: 35082528
• Getz KD, Szymczak JE, Li Y, Madding R, Huang YV, Aftandilian C, Arnold SD, Bona KO, Caywood E, Collier AB, Gramatges MM, Henry M, Lotterman C, Maloney K, Mian A, Mody R, Morgan E, Raetz EA, Rubnitz J, Verma A, Winick N, Wilkes JJ, Yu JC, Fisher BT, Aplenc R. Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia. JAMA Netw Open. 2021 Oct 1;4(10):e2128385. PubMed PMID: 34709389
• Hecht A, Meyer JA, Behnert A, Wong E, Chehab F, Olshen A, Hechmer A, Aftandilian C, Bhat R, Choi SW, Chonat S, Farrar JE, Fluchel M, Frangoul H, Han JH, Kolb EA, Kuo DJ, MacMillan ML, Maese L, Maloney KW, Narendran A, Oshrine B, Schultz KR, Sulis ML, Van Mater D, Tasian SK, Hofmann WK, Loh ML, Stieglitz E. Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia. Haematologica. 2022 Jan 1;107(1):178-186. PubMed PMID: 33375775
• Rabin KR, Devidas M, Chen Z, Ji L, Kairalla J, Hitzler JK, Yang JJ, Carroll AJ, Heerema NA, Borowitz MJ, Wood BL, Roberts KG, Mullighan CG, Harvey RC, Chen IM, Willman CL, Reshmi SC, Gastier-Foster JM, Bhojwani D, Rheingold SR, Maloney KW, Mattano LA, Larsen EC, Schore RJ, Burke MJ, Salzer WL, Winick NJ, Carroll WL, Raetz EA, Loh ML, Hunger SP, Angiolillo AL. Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group. J Clin Oncol. 2023 Oct 27;:JCO2300389. [Epub ahead of print] PubMed PMID: 37890117
• Schore RJ, Angiolillo AL, Kairalla JA, Devidas M, Rabin KR, Zweidler-McKay P, Borowitz MJ, Wood B, Carroll AJ, Heerema NA, Relling MV, Hitzler J, Kadan-Lottick NS, Maloney K, Wang C, Carroll WL, Winick NJ, Raetz EA, Loh ML, Hunger SP. Correction: Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932. Leukemia. 2023 Jun;37(6):1406. PubMed PMID: 37157018
• Schore RJ, Angiolillo AL, Kairalla JA, Devidas M, Rabin KR, Zweidler-McKay P, Borowitz MJ, Wood B, Carroll AJ, Heerema NA, Relling MV, Hitzler J, Kadan-Lottick NS, Maloney K, Wang C, Carroll WL, Winick NJ, Raetz EA, Loh ML, Hunger SP. Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932. Leukemia. 2023 Jun;37(6):1375-1378. PubMed PMID: 36966262
• Gupta S, Dai Y, Chen Z, Winestone LE, Teachey DT, Bona K, Aplenc R, Rabin KR, Zweidler-McKay P, Carroll AJ, Heerema NA, Gastier-Foster J, Borowitz MJ, Wood BL, Maloney KW, Mattano LA Jr, Larsen EC, Angiolillo AL, Burke MJ, Salzer WL, Winter SS, Brown PA, Guest EM, Dunsmore KP, Kairalla JA, Winick NJ, Carroll WL, Raetz EA, Hunger SP, Loh ML, Devidas M. Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials. Lancet Haematol. 2023 Feb;10(2):e129-e141. PubMed PMID: 36725118
• Demedis J, Scarbro S, Suresh K, Maloney K, Forlenza GP. Hyperglycemia and Other Glycemic Measures Throughout Therapy for Pediatric Acute Lymphoblastic Leukemia and Lymphoma. J Pediatr Hematol Oncol. 2023 Mar 1;45(2):e154-e160. PubMed PMID: 36715999
• Barth M, Xavier AC, Armenian S, Audino AN, Blazin L, Bloom D, Chung J, Davies K, Ding H, Ford JB, Galardy PJ, Hanna R, Hayashi R, Lee-Miller C, Machnitz AJ, Maloney KW, Marks L, Martin PL, McCall D, Pacheco M, Reilly AF, Roshal M, Song S, Weinstein J, Zarnegar-Lumley S, McMillian N, Schonfeld R, Sundar H. Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 Nov;20(11):1267-1275. PubMed PMID: 36351334
• Elgarten CW, Otto WR, Shenton L, Stein MT, Horowitz J, Aftandilian C, Arnold SD, Bona KO, Caywood E, Collier AB, Gramatges MM, Henry M, Lotterman C, Maloney K, Modi AJ, Mian A, Mody R, Morgan E, Raetz EA, Verma A, Winick N, Wilkes JJ, Yu JC, Aplenc R, Fisher BT, Getz KD. Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia. Infect Control Hosp Epidemiol. 2023 Feb;44(2):222-229. PubMed PMID: 35465865
• Gupta S, Teachey DT, Chen Z, Rabin KR, Dunsmore KP, Larsen EC, Maloney KW, Mattano LA Jr, Winter SS, Carroll AJ, Heerema NA, Borowitz MJ, Wood BL, Carroll WL, Raetz EA, Winick NJ, Loh ML, Hunger SP, Devidas M. Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report. Cancer. 2022 May 1;128(9):1863-1870. PubMed PMID: 35201611

Professional Memberships

• American Society of Hematology, Member
• Alpha Omega Alpha Medical Honor Society, Member
• Children’s Oncology Group, Co-Chair, Standard Risk ALL
• American Society of Pediatric Hematology/Oncology, Member

Practice Locations

• Children's Hospital Colorado

Specialty Information

• Pediatric Hematology / Oncology, Board Certification (2005)

• Blood / Lymphatic System - Blood Disorders
• Cancers - Leukemia (Childhood)
• Blood / Lymphatic System
• Cancers